Literature DB >> 19562866

Tumor necrosis factor inhibitors in the treatment of chronic inflammatory diseases. A review of immunogenicity and potential implications.

Joseph Flood1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562866

Source DB:  PubMed          Journal:  Manag Care        ISSN: 1062-3388


× No keyword cloud information.
  3 in total

1.  Is extrapolation of the safety and efficacy data in one indication to another appropriate for biosimilars?

Authors:  Howard Lee
Journal:  AAPS J       Date:  2013-10-11       Impact factor: 4.009

2.  Are different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?

Authors:  Nahren Manuel Mascarenhas; Johannes Kästner
Journal:  BMC Struct Biol       Date:  2012-05-08

Review 3.  Current status of biosimilars in the treatment of inflammatory bowel diseases.

Authors:  Dong Il Park
Journal:  Intest Res       Date:  2016-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.